The importance of the domain of applicability in QSAR modeling
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
p-σ-π Analysis. A Method for the Correlation of Biological Activity and Chemical Structure
Hansch, C., & Fujita, T. (1964) · Journal of the American Chemical Society · doi:10.1021/ja01062a035 · Cited by 2,313
Clinical biomarkers in drug discovery and development
Frank, R., & Hargreaves, R. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1130 · Cited by 794
Hall, L. H., & Kier, L. B. (1995) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci00028a014 · Cited by 763
Managing the drug discovery/development interface
Kennedy, T. (1997) · Drug Discovery Today · doi:10.1016/s1359-6446(97)01099-4 · Cited by 522
Pharmaceutical innovation by the seven UK‐owned pharmaceutical companies (1964‐1985).
Prentis, R., Lis, Y., & Walker, Sr. (1988) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1988.tb03318.x · Cited by 471
Molecular identification number for substructure searches
Burden, F. R. (1989) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci00063a011 · Cited by 320
Similarity to Molecules in the Training Set Is a Good Discriminator for Prediction Accuracy in QSAR
Sheridan, R. P., Feuston, B. P., Maiorov, V. N., & Kearsley, S. K. (2004) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci049782w · Cited by 298
Prediction of ADMET Properties
Norinder, U., & Bergström, C. A. S. (2006) · ChemMedChem · doi:10.1002/cmdc.200600155 · Cited by 285
Can we estimate the accuracy of ADME–Tox predictions?
Tetko, I. V., Bruneau, P., Mewes, H.-W., Rohrer, D. C., & Poda, G. I. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.06.013 · Cited by 243
Gedeck, P., Rohde, B., & Bartels, C. (2006) · Journal of Chemical Information and Modeling · doi:10.1021/ci050413p · Cited by 218
Cited by
In silico toxicology: computational methods for the prediction of chemical toxicity
Raies, A. B., & Bajic, V. B. (2016) · WIREs Computational Molecular Science · doi:10.1002/wcms.1240 · Cited by 744
Comparison of Different Approaches to Define the Applicability Domain of QSAR Models
Sahigara, F., Mansouri, K., Ballabio, D., Mauri, A., Consonni, V., & Todeschini, R. (2012) · Molecules · doi:10.3390/molecules17054791 · Cited by 633
Big-Data Science in Porous Materials: Materials Genomics and Machine Learning
Jablonka, K. M., Ongari, D., Moosavi, S. M., & Smit, B. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00004 · Cited by 599
Quantitative Structure–Property Relationship Modeling of Diverse Materials Properties
Le, T., Epa, V. C., Burden, F. R., & Winkler, D. A. (2012) · Chemical Reviews · doi:10.1021/cr200066h · Cited by 565
Autonomy in materials research: a case study in carbon nanotube growth
Nikolaev, P., Hooper, D., Webber, F., Rao, R., Decker, K., Krein, M., Poleski, J., Barto, R., & Maruyama, B. (2016) · npj Computational Materials · doi:10.1038/npjcompumats.2016.31 · Cited by 379
Time-Split Cross-Validation as a Method for Estimating the Goodness of Prospective Prediction.
Sheridan, R. P. (2013) · Journal of Chemical Information and Modeling · doi:10.1021/ci400084k · Cited by 376
Carpenter, T. S., Kirshner, D. A., Lau, E. Y., Wong, S. E., Nilmeier, J. P., & Lightstone, F. C. (2014) · Biophysical Journal · doi:10.1016/j.bpj.2014.06.024 · Cited by 306
In silico toxicology for the pharmaceutical sciences☆
Valerio Jr., L. G. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.08.022 · Cited by 296
Wang, N.-N., Dong, J., Deng, Y.-H., Zhu, M.-F., Wen, M., Yao, Z.-J., Lu, A.-P., Wang, J.-B., & Cao, D.-S. (2016) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5b00642 · Cited by 242
Towards reproducible computational drug discovery
Schaduangrat, N., Lampa, S., Simeon, S., Gleeson, M. P., Spjuth, O., & Nantasenamat, C. (2020) · Journal of Cheminformatics · doi:10.1186/s13321-020-0408-x · Cited by 208
Self-citationClassification of Cytochrome P450 Inhibitors and Noninhibitors Using Combined Classifiers
Cheng, F., Yu, Y., Shen, J., Yang, L., Li, W., Liu, G., Lee, P. W., & Tang, Y. (2011) · Journal of Chemical Information and Modeling · doi:10.1021/ci200028n · Cited by 196
Lei, T., Li, Y., Song, Y., Li, D., Sun, H., & Hou, T. (2016) · Journal of Cheminformatics · doi:10.1186/s13321-016-0117-7 · Cited by 174
In Silico Toxicology – Non-Testing Methods
Raunio, H. (2011) · Frontiers in Pharmacology · doi:10.3389/fphar.2011.00033 · Cited by 167
“…higher reproducibility if the have low compound synthesis requirements have potential to reduce the use of animals Limitations include (Weaver and Gleeson, 2008; quality and transparency of training set experimental data applicability domain sometimes not thus explaining underlying systems, but…”
BackgroundDual Inhibitors of AChE and BACE-1 for Reducing Aβ in Alzheimer’s Disease: From In Silico to In Vivo
Stern, N., Gacs, A., Tátrai, E., Flachner, B., Hajdú, I., Dobi, K., Bágyi, I., Dormán, G., Lőrincz, Z., Cseh, S., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113098 · Cited by 35
“For AvI, we restricted the random picking of molecules to those that had some properties that were close to the average of each of four properties of the actives: H-bond donors and acceptors, molecular weight and calculated logP, according to the important principle of “applicability domain” [43].”
MethodDiscovery of neuroprotective compounds by machine learning approaches
Fang, J., Pang, X., Yan, R., Lian, W., Li, C., Wang, Q., Liu, A.-L., & Du, G.-H. (2016) · RSC Advances · doi:10.1039/c5ra23035g · Cited by 31
Metadata
- Authors
- Weaver, S., & Gleeson, M. P.
- Venue
- Journal of Molecular Graphics and Modelling
- Publisher
- Elsevier BV
- Published
- 2008-06
- Volume
- 26
- Issue
- 8
- Pages
- 1315-1326
- ISSN
- 1093-3263 (ISSN-L)
- OpenAlex
- W2015931265
- Cited by
- 338
- References
- 28
- FWCI
- 16.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.